Would you offer ultrahypofractionated 5-fraction whole breast only adjuvant radiation for a women with ER-/HER2+/cN+ disease with pCR in breast and nodes following Herceptin based neoadjuvant systemic therapy followed by breast conservation therapy with sentinel lymph node biopsy?